Mulmit

Protalix BioTherapeutics, Inc.Protalix BioTherapeutics, Inc.

PLX NYSE

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3152,744,000-5,500,000-6,604,000-0.08
2024-12-3153,399,0003,917,0002,932,0000.04
2023-12-3165,494,00010,460,0008,312,0000.09
2022-12-3147,638,000-13,014,000-14,927,000-0.31
2021-12-3138,350,000-20,462,000-27,582,000-0.62

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-03Schwartz Aharon17,000
2026-09-03Schwartz Aharon8,500
2026-09-03Elze Christian17,000
2026-09-03Elze Christian8,500
2026-09-03Ben Zvi Shmuel17,000
2026-09-03Ben Zvi Shmuel8,500
2026-09-03Forster Eliot17,000
2026-09-03Forster Eliot8,500
2026-09-03Bashan DrorPRESIDENT AND CEO320,000
2026-09-03Bashan DrorPRESIDENT AND CEO160,000
2026-09-03Naos YaronSr. VP & COO112,000
2026-09-03Naos YaronSr. VP & COO56,000

8-K events

FiledItems
2026-08-12Results of operations · Financial statements and exhibits
2026-06-25Submission of matters to a vote · Financial statements and exhibits
2026-05-21Regulation FD disclosure · Financial statements and exhibits
2026-05-13Results of operations · Financial statements and exhibits
2026-03-18Results of operations · Financial statements and exhibits
2026-03-09Other events · Financial statements and exhibits
2026-02-11Regulation FD disclosure · Financial statements and exhibits
2026-01-30Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.